A global perspective of lung transplantation: Part 1 - Recipient selection and choice of procedure

Reda E. Girgis, Asghar Khaghani


Lung transplantation has grown considerably in recent years and its availability has spread to an expanding number of countries worldwide. Importantly, survival has also steadily improved, making this an increasingly viable procedure for patients with end-stage lung disease and limited life expectancy. In this first of a series of articles, recipient selection and type of transplant operation are reviewed. Pulmonary fibrotic disorders are now the most indication in the U.S., followed by chronic obstructive pulmonary disease and cystic fibrosis. Transplant centers have liberalized criteria to include older and more critically ill candidates. A careful, systematic, multi-disciplinary selection process is critical in identifying potential barriers that may increase risk and optimize long-term outcomes. 

Full Text:


DOI: http://dx.doi.org/10.21542/gcsp.2016.5


  • There are currently no refbacks.

Copyright (c) 2016 Reda E. Girgis, Asghar Khaghani

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.